Replies to post #3467 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

We’ve discussed the ATryn transfer price with Leo on so many occasions that I don’t think there is anything new to add. Either you believe management when they say the economic terms make sense for GTC or you don’t. We won’t have hard numbers with which to gauge the profit margin until enough product is being sold to Leo for the financial metrics to be meaningful.